These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34626556)

  • 1. Crunching the numbers for viral hepatitis.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):875. PubMed ID: 34626556
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C eradication: A long way to go.
    Waheed Y
    World J Gastroenterol; 2015 Nov; 21(43):12510-2. PubMed ID: 26604658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicine. Hepatitis C can be cured globally, but at what cost?
    Hill A; Cooke G
    Science; 2014 Jul; 345(6193):141-2. PubMed ID: 25013048
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C drugs not reaching poor.
    Callaway E
    Nature; 2014 Apr; 508(7496):295-6. PubMed ID: 24740042
    [No Abstract]   [Full Text] [Related]  

  • 5. Access to HCV treatments: hurdles not barriers.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2017 Jan; 2(1):1. PubMed ID: 28404005
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of hepatitis B virus infection in the underprivileged world.
    Almasio PL; Craxì A
    Liver Int; 2011 Jul; 31(6):749-50. PubMed ID: 21645204
    [No Abstract]   [Full Text] [Related]  

  • 7. A new direction for hepatitis C.
    The Lancet
    Lancet; 2014 Apr; 383(9925):1270. PubMed ID: 24725562
    [No Abstract]   [Full Text] [Related]  

  • 8. Universal Medicine Access through Lump-Sum Remuneration - Australia's Approach to Hepatitis C.
    Moon S; Erickson E
    N Engl J Med; 2019 Feb; 380(7):607-610. PubMed ID: 30763190
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C drug affordability.
    Kamal-Yanni M
    Lancet Glob Health; 2015 Feb; 3(2):e73-4. PubMed ID: 25617196
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening urged for hepatitis C but drug costs are prohibitive.
    Fralick M
    CMAJ; 2014 Mar; 186(5):329. PubMed ID: 24549123
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of new hepatitis C treatments in different regions of the world.
    Wei L; Lok AS
    Gastroenterology; 2014 May; 146(5):1145-50.e1-4. PubMed ID: 24662488
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areas.
    Lemoine M; Thursz M
    Semin Liver Dis; 2014 Feb; 34(1):89-97. PubMed ID: 24782262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A path to eradication of hepatitis C in low- and middle-income countries.
    Graham CS; Swan T
    Antiviral Res; 2015 Jul; 119():89-96. PubMed ID: 25615583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C treatment in Guatemala: the struggle for access.
    Webster P
    Lancet; 2018 Jul; 392(10144):269-270. PubMed ID: 30064642
    [No Abstract]   [Full Text] [Related]  

  • 15. Eliminating hepatitis C.
    Burki T
    Lancet Infect Dis; 2019 Mar; 19(3):246-247. PubMed ID: 30833063
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.
    Soriano V; Tefferi A
    Cancer; 2018 Apr; 124(8):1647-1649. PubMed ID: 29486060
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monoclonal antibodies worldwide and for all?].
    Hirsch F
    Med Sci (Paris); 2019 Dec; 35(12):1196-1197. PubMed ID: 31903938
    [No Abstract]   [Full Text] [Related]  

  • 18. Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?
    Assefa Y; Hill PS; Ulikpan A; Williams OD
    Global Health; 2017 Sep; 13(1):73. PubMed ID: 28903757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New hepatitis C therapies: the toolbox, strategies, and challenges.
    Pawlotsky JM
    Gastroenterology; 2014 May; 146(5):1176-92. PubMed ID: 24631495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leaving no one behind: Towards equitable global elimination of hepatitis C.
    Dahl EH; Zahid H; Aslam K; Jafri W
    J Glob Health; 2020 Jun; 10(1):010308. PubMed ID: 32257136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.